Segall Bryant & Hamill’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,798	Closed	-$391K	–	725
2023 Q2	$391K	Hold	3,798	–	–	﹤0.01%	599
2023 Q1	$414K	Sell	3,798 -126,746	-97%	-$14M	﹤0.01%	597
2022 Q4	$14.9M	Sell	130,544 -51,149	-28%	-$4.25M	0.17%	170
2022 Q3	$11.2M	Buy	181,693 +44,072	+32%	+$3.08M	0.13%	187
2022 Q2	$11M	Sell	137,621 -25,094	-15%	-$2.38M	0.12%	185
2022 Q1	$17.1M	Buy	162,715 +30,834	+23%	+$3M	0.16%	152
2021 Q4	$14.2M	Sell	131,881 -4,024	-3%	-$439K	0.13%	175
2021 Q3	$14.9M	Sell	135,905 -15,811	-10%	-$1.64M	0.14%	164
2021 Q2	$14.2M	Buy	151,716 +15,165	+11%	+$1.4M	0.14%	172
2021 Q1	$12.6M	Sell	136,551 -32,763	-19%	-$2.76M	0.12%	189
2020 Q4	$12.4M	Buy	169,314 +9,136	+6%	+$679K	0.14%	169
2020 Q3	$12.4M	Buy	160,178 +37,432	+30%	+$2.58M	0.17%	138
2020 Q2	$6.82M	Sell	122,746 -20,904	-15%	-$894K	0.11%	182
2020 Q1	$4.26M	Buy	143,650 +13,296	+10%	+$450K	0.09%	217
2019 Q4	$4.72M	Sell	130,354 -6,347	-5%	-$195K	0.07%	259
2019 Q3	$3.72M	Sell	136,701 -22,169	-14%	-$573K	0.06%	315
2019 Q2	$3.82M	Buy	158,870 +7,389	+5%	+$187K	0.06%	313
2019 Q1	$4M	Sell	151,481 -138,972	-48%	-$3.29M	0.06%	305
2018 Q4	$5.67M	Sell	290,453 -173,995	-37%	-$3.41M	0.1%	244
2018 Q3	$9.09M	Sell	464,448 -167,885	-27%	-$3.19M	0.13%	205
2018 Q2	$10.5M	Sell	632,333 -50,777	-7%	-$774K	0.16%	176
2018 Q1	$9.7M	Sell	683,110 -41,892	-6%	-$619K	0.22%	114
2017 Q4	$10.6M	Buy	725,002 +81,074	+13%	+$1.14M	0.23%	114
2017 Q3	$8.16M	Buy	643,928 +52,454	+9%	+$667K	0.19%	129
2017 Q2	$7.02M	Buy	+591,474	New	+$7.36M	0.17%	138